Biocompatibility Evaluation of Porcine-Derived Collagen Sheets for Clinical Applications: In Vitro Cytotoxicity, In Vivo Sensitization, and Intracutaneous Reactivity Studies
Source abstract
Abstract
Biocompatibility evaluation of medical devices is essential for ensuring safety, with ISO 10993 series being the standard. However, these tests can be time-consuming and resource-intensive. This study assessed the early-stage biocompatibility of a collagen matrix derived from porcine dermis using three selective ISO tests: in vitro cytotoxicity, in vivo sensitization, and irritation. Collagen was hydrolyzed, purified from miniature pig skin, and then processed into porous sheets via lyophilization. Extracts were prepared using both polar and non-polar extraction vehicles for biological testing. Cytotoxicity testing with mouse fibroblast cells showed no significant cytotoxic effects, with cell morphology and viability comparable to controls. Sensitization testing in guinea pigs, involving intradermal and topical exposure, revealed no allergic responses. Irritation testing in rabbits showed no signs of irritation. The cytotoxicity test took 3 days, the sensitization test 28 days, and the irritation test 7 days, all of which proved suitable for early biocompatibility screening. These results confirmed that the collagen matrix is non-cytotoxic, non-sensitizing, and non-irritant for a month. The use of these three tests enables early identification of unsafe materials, reducing time, cost, and animal use before advancing to more complex ISO 10993 studies. Therefore, they are appropriate and necessary for early feasibility decisions in medical device development.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Collagen: Extraction and Characterization · 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
D.med LLC, 111, Sagimakgol-ro, Jungwon-gu, Seongnam-si 13202, Gyeonggi-do, Republic of Korea
Shiley Center for Orthopaedic Research and Education at Scripps Clinic, 3550 John Hopkins Ct, Suite 110, San Diego, CA 92121, USA
References (51)
Show source-provided references
1. Ni, H., Liu, C., Kong, L., Zhai, L., Chen, J., Liu, Q., Chen, Z., Wu, M., Chen, J., and Guo, Y. (2023). Preparation of injectable porcine skin-derived collagen and its application in delaying skin aging by promoting the adhesion and chemotaxis of skin fibroblasts. Int. J. Biol. Macromol., 253.10.1016/j.ijbiomac.2023.126718 ↗
2. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications10.1016/j.mser.2021.100641 ↗
3. Amirrah, I.N., Lokanathan, Y., Zulkiflee, I., Wee, M., Motta, A., and Fauzi, M.B. (2022). A Comprehensive Review on Collagen Type I Development of Biomaterials for Tissue Engineering: From Biosynthesis to Bioscaffold. Biomedicines, 10.10.3390/biomedicines10092307 ↗
4. Collagen as the extracellular matrix biomaterials in the arena of medical sciences10.1016/j.tice.2024.102497 ↗
5. Wang, H. (2021). A Review of the Effects of Collagen Treatment in Clinical Studies. Polymers, 13.10.3390/polym13223868 ↗
6. Elastin and collagen fibres in cutaneous wound healing10.1111/exd.15052 ↗
7. Wosicka-Frąckowiak, H., Poniedziałek, K., Woźny, S., Kuprianowicz, M., Nyga, M., Jadach, B., and Milanowski, B. (2024). Collagen and Its Derivatives Serving Biomedical Purposes: A Review. Polymers, 16.10.20944/preprints202408.1673.v1 ↗
8. Use of Collagen in Cosmetic Products10.3390/cimb46030132 ↗
9. Immune Responses to Allogeneic and Xenogeneic Implants of Collagen and Collagen Derivatives10.1097/00003086-199011000-00043 ↗
10. Collagen and Its Modifications—Crucial Aspects with Concern to Its Processing and Analysis10.1002/mame.201600460 ↗
11. Collagen Degradation10.3109/03008208209034406 ↗
12. Matinong, A.M.E., Chisti, Y., Pickering, K.L., and Haverkamp, R.G. (2022). Collagen Extraction from Animal Skin. Biology, 11.10.3390/biology11060905 ↗
13. Lee, E.H., Chun, S.Y., Lee, J.N., Yoon, B.H., Chung, J.-W., Han, M.-H., Kwon, T.G., Ha, Y.-S., and Kim, B.S. (2022). Optimized Collagen Extraction Process to Obtain High Purity and Large Quantity of Collagen from Human Perirenal Adipose Tissue. BioMed Res. Int., 2022.10.1155/2022/3628543 ↗
14. Advanced technologies for the collagen extraction from food waste—A review on recent progress10.1016/j.microc.2024.110404 ↗
15. Harris, M., Potgieter, J., Ishfaq, K., and Shahzad, M. (2021). Developments for Collagen Hydrolysate in Biological, Biochemical, and Biomedical Domains: A Comprehensive Review. Materials, 14.10.3390/ma14112806 ↗
16. Beheshtizadeh, N., Gharibshahian, M., Pazhouhnia, Z., Rostami, M., Zangi, A.R., Maleki, R., Azar, H.K., Zalouli, V., Rajavand, H., and Farzin, A. (2022). Commercialization and regulation of regenerative medicine products: Promises, advances and challenges. Biomed. Pharmacother., 153.10.1016/j.biopha.2022.113431 ↗
17. About ATMPs, SOPs and GMP: The Hurdles to Produce Novel Skin Grafts for Clinical Use10.1159/000447645 ↗
18. Hydrolyzed collagen: Exploring its applications in the food and beverage industries and assessing its impact on human health—A comprehensive review10.1016/j.heliyon.2024.e36433 ↗
19. Deciphering the Wound-Healing Potential of Collagen Peptides and the Molecular Mechanisms: A Review10.1021/acs.jafc.4c02960 ↗
20. The application of collagen sheet in open wound healing
21. León-López, A., Morales-Peñaloza, A., Martínez-Juárez, V.M., Vargas-Torres, A., Zeugolis, D.I., and Aguirre-Álvarez, G. (2019). Hydrolyzed Collagen-Sources and Applications. Molecules, 24.10.3390/molecules24224031 ↗
22. Alberts, A., Bratu, A.G., Niculescu, A.-G., and Grumezescu, A.M. (2025). Collagen-Based Wound Dressings: Innovations, Mechanisms, and Clinical Applications. Gels, 11.10.3390/gels11040271 ↗
23. Collagen Tissue Engineering: Development of Novel Biomaterials and Applications10.1203/PDR.0b013e31816c5bc3 ↗
24. Native collagen sheet mask improves skin health and appearance: A comprehensive clinical evaluation10.1111/jocd.16181 ↗
25. Kanďárová, H., and Pôbiš, P. (2023). The “Big Three” in biocompatibility testing of medical devices: Implementation of alternatives to animal experimentation-are we there yet?. Front. Toxicol., 5.10.3389/ftox.2023.1337468 ↗
26. (2009). Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity (Standard No. ISO 10993-5:2009).
27. (2021). Biological Evaluation of Medical Devices—Part 10: Tests for Skin Sensitization (Standard No. ISO 10993-10:2021).
28. (2021). Biological Evaluation of Medical Devices—Part 23: Tests for Irritation (Standard No. ISO 10993-23:2021).
29. Frisch, E., Clavier, L., Belhamdi, A., Vrana, N.E., Lavalle, P., Frisch, B., Heurtault, B., and Gribova, V. (2023). Preclinical in vitro evaluation of implantable materials: Conventional approaches, new models and future directions. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1193204 ↗
30. Ambrosio, L. (2017). 13—The challenge of biocompatibility evaluation of biocomposites. Biomedical Composites, Woodhead Publishing. [2nd ed.].
31. Koo, T.H., Lee, J.K., Grogan, S.P., Ra, H.J., and D’Lima, D.D. (2024). Biocompatibility Study of Purified and Low-Temperature-Sterilized Injectable Collagen for Soft Tissue Repair: Intramuscular Implantation in Rats. Gels, 10.10.20944/preprints202408.1229.v1 ↗
32. Subcutaneous toxicity of a dual ionically cross-linked atelocollagen and sodium hyaluronate gel: Rat in vivo study for biological safety evaluation of the injectable hydrogel10.1016/j.toxrep.2021.09.001 ↗
33. (2021). Biological Evaluation of Medical Devices—Part 12: Sample Preparation and Reference Materials (Standard No. ISO 10993-12:2021).
34. Trypan Blue Exclusion Test of Cell Viability10.1002/0471142735.ima03bs111 ↗
35. Boutrand, J.-P. (2012). 7—In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices, Woodhead Publishing.10.1533/9780857096456 ↗
36. Development of porcine skeletal muscle extracellular matrix–derived hydrogels with improved properties and low immunogenicity10.1073/pnas.2322822121 ↗
37. Lack of immunogenicity of xenogeneic DNA from porcine biomaterials10.1016/j.sopen.2022.07.005 ↗
38. Tai, H.C., Liao, Y.H., Chang, Y.C., Yang, C.Y., Horng, S.Y., Kuo, Y.S., Sheen, Y.S., Huang, Y.H., Hui, R.C., and Chen, T.M. (2024). An Evaluation of Skin and Immunological Responses after Using a Novel Cross-Linked Porcine-Based Dermal Injectable Collagen with Lidocaine for Nasolabial Fold Correction. J. Clin. Med., 13.10.3390/jcm13175241 ↗
39. Immunogenicity in xenogeneic scaffold generation: Antigen removal vs. decellularization10.1016/j.actbio.2014.01.028 ↗
40. Elango, J., Hou, C., Bao, B., Wang, S., Maté Sánchez de Val, J.E., and Wenhui, W. (2022). The Molecular Interaction of Collagen with Cell Receptors for Biological Function. Polymers, 14.10.3390/polym14050876 ↗
41. Ricard-Blum, S. (2011). The collagen family. Cold Spring Harb. Perspect. Biol., 3.10.1101/cshperspect.a004978 ↗
42. Collagen-binding growth factors: Production and characterization of functional fusion proteins having a collagen-binding domain10.1073/pnas.95.12.7018 ↗
43. Use of collagen as a biomaterial: An update10.4103/0972-124X.118333 ↗
44. Advanced application of collagen-based biomaterials in tissue repair and restoration10.1186/s42825-022-00102-6 ↗
45. Jablonská, E., Kubásek, J., Vojtěch, D., Ruml, T., and Lipov, J. (2021). Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials. Sci. Rep., 11.10.1038/s41598-021-85019-6 ↗
46. Podgórski, R., Wojasiński, M., and Ciach, T. (2022). Nanofibrous materials affect the reaction of cytotoxicity assays. Sci. Rep., 12.10.1038/s41598-022-13002-w ↗
47. Gruber, S., and Nickel, A. (2023). Toxic or not toxic? The specifications of the standard ISO 10993-5 are not explicit enough to yield comparable results in the cytotoxicity assessment of an identical medical device. Front. Med. Technol., 5.10.3389/fmedt.2023.1195529 ↗
48. Fadeel, B., Pietroiusti, A., and Shvedova, A.A. (2012). Chapter 4—Critical Evaluation of Toxicity Tests. Adverse Effects of Engineered Nanomaterials, Academic Press.
49. Redefining biomaterial biocompatibility: Challenges for artificial intelligence and text mining10.1016/j.tibtech.2023.09.015 ↗
50. Ambrosio, L. (2017). 15—Testing the in vivo biocompatibility of biocomposites. Biomedical Composites, Woodhead Publishing. [2nd ed.].
51. Davison-Kotler, E., Marshall, W.S., and García-Gareta, E. (2019). Sources of Collagen for Biomaterials in Skin Wound Healing. Bioengineering, 6.10.3390/bioengineering6030056 ↗